Table 2.
Canonical pathway analysis of 719 genes differentially expressed with aging in retinal microglia.
| Canonical Pathways | Age-related genes | Ratio1 | P-value |
|---|---|---|---|
| Pathways related to microglial immune function and regulation | |||
|
| |||
| IL-17A Signaling | FOS, JUN, MAPK10, TNF | 0.1600 | 0.010000 |
| Ceramide Signaling | S1PR4, FOS, JUN, S1PR5, PIK3C2A, TNFRSF1A, PPM1L, PIK3R6, MRAS, PPP2R5E, TNF | 0.1260 | 0.000071 |
| IL-3 Signaling | FOS, PRKCI, J UN, PIK3C2A, CHP, PIK3R6, MRAS, PRKCE | 0.1080 | 0.002951 |
| IL-1 Signaling | GNB1, FOS, JUN, PRKAR2B, MYD88, GNAO1, MRAS, MAPK10, PRKAR2A, GNG3, ADCY7 | 0.1040 | 0.000288 |
| Nitric Oxide Signaling | VEGFA, BDKRB2, PRKAR2B, GUCY1A3, PIK3C2A, KDR, PIK3R6, CAV1, PRKAR2A, SLC7A1 | 0.1000 | 0.000372 |
| Estrogen-Dependent Breast Cancer Signaling | FOS, JUN, PIK3C2A, PIK3R6, MRAS, HSD17B12, HSD17B1 | 0.1000 | 0.004365 |
| LPS-stimulated MAPK Signaling | FOS, PRKCI, JUN, PIK3C2A, PIK3R6, MRAS, MAPK10, PRKCE | 0.0976 | 0.003548 |
|
| |||
| Pathways related to angiogenesis | |||
|
| |||
| Inhibition of Angiogenesis by TSP1 | VEGFA, JUN, GUCY1A3, KDR, MAPK10, CD36 | 0.1540 | 0.000955 |
| VEGF Family Ligand-Receptor Interactions | VEGFA, FOS, PRKCI, PIK3C2A, KDR, PLA2G5, PIK3R6, MRAS, PRKCE | 0.1070 | 0.001175 |
|
| |||
| Pathways related to trophic factors | |||
|
| |||
| Neurotrophin/TRK Signaling | FOS, JUN, Klk1b1, PIK3C2A, SPRY2, PIK3R6, MRAS, SORCS1 | 0.1100 | 0.001698 |
Number of genes in the list of age-related genes in a given canonical pathway divided by the total number of genes mapping to that pathway.